TRANSGENE BIOTEK LTD. Share Price

TRANSGENE BIOTEK LTD. Share Price

BSE: 526139
|
Healthcare Services
|
S Cap
₹ 2.77
-₹0.09 (-3.15%)
1D
Last updated 11 Sep, 2026, 15:21 IST

TRANSGENE BIOTEK LTD. Share Price Today

As of 11 Sep 2026, TRANSGENE BIOTEK LTD. share price is ₹2.77. The stock opened at ₹2.85, compared to its previous close of ₹2.86. During today's trading session, TRANSGENE BIOTEK LTD. share price moved in the range of ₹2.72 to ₹2.85, with an average price of ₹2.79 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.83 and a high of ₹4.50.

₹2.72
3.15% down today
₹2.85
1D LOW
1D HIGH

TRANSGENE BIOTEK LTD. Returns Calculator

Circuit
L
H
₹2.29
₹3.43
52-week
L
H
₹1.83
₹4.50

About TRANSGENE BIOTEK LTD.

TRANSGENE BIOTEK LTD. Share Price
ISIN
INE773D01018
Sector Market Cap
₹ 21.67 Cr

Transgene Biotek Limited is an India-based biotechnology company. It is engaged in the research and development of vaccines, oncology, and new drug delivery technologies. Its portfolio of products includes oncology, autoimmunity, drug delivery and biogenetics. The Company offers TrabiAAV, which is a platform for the delivery of micro-ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL drug is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203 drug is used to strengthen cell-mediated immunity and complete the elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus drug suppresses the immune system and is mainly used to prevent rejection of transplanted organs.

TRANSGENE BIOTEK LTD. Financial Highlights

  • Revenue: TRANSGENE BIOTEK LTD. reported revenue of ₹0.36 crore in FY26 vs ₹1.04 crore in FY25. It showed a decrease of 65.38% on a yearly basis.
  • Operating Profit: TRANSGENE BIOTEK LTD. reported an operating loss of ₹1.65 crore in FY26 vs ₹0.68 crore in FY25. It showed a decrease of 142.65% on a year-on-year basis.
  • Net Profit: TRANSGENE BIOTEK LTD. reported a net loss of ₹1.65 crore in FY26 vs ₹0.68 crore in FY25. It showed a decrease of 142.65% on a yearly basis.

TRANSGENE BIOTEK LTD. Quarterly Result Highlights

  • TRANSGENE BIOTEK LTD. reported revenue of ₹0.06 crore in Jun 2026, compared with ₹0.20 crore in Mar 2026, representing a decrease of 70.00% on a quarter-on-quarter (QoQ) basis.
  • TRANSGENE BIOTEK LTD. reported an operating loss of ₹0.39 crore in Jun 2026, compared with ₹0.46 crore in Mar 2026, representing an increase of 15.22% on a quarter-on-quarter (QoQ) basis.
  • TRANSGENE BIOTEK LTD. reported a loss of ₹0.39 crore in Jun 2026, compared with ₹0.46 crore in Mar 2026, reflecting an increase of 15.22% on a QoQ basis.
  • The earnings per share (EPS) of TRANSGENE BIOTEK LTD. stood at ₹0.09 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
23.64%
FII
0.00%
Other DII
0.00%
Retail and other
76.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
21.67
P/E
-13.62
P/B
2.59
ROE
-19.73%
D/E
-1.86
ROCE
-2.32%
Div. Yield
0.00%
EPS(TTM)
-0.22
Turnover
0.01
EV/EBITDA
-122.79
Net Margin
0.00%
Op. Margin
0.00%
ROA
-1.12%
Quick Ratio
0.00
Curr. Ratio
0.36
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
Transgene Biotek outperforming most market indices
Step 1 of 5
Valuation
Overvalued
Transgene Biotek appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Transgene Biotek earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,27,609.0058.7513.4620.48%0.3217.27%692.920.23%0.66103.81
Max Healthcare1,01,127.0069.419.4113.42%0.0912.97%91.840.19%0.277.37
MANIPAL HEALTH ENTERPRI L96,430.30106.405.8710.59%0.469.51%0.000.00%0.000.00
Fortis Healthcare68,082.1063.606.8810.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare67,994.80184.3015.898.48%0.3110.10%49.230.00%0.435.20
Global Health39,243.2071.069.9114.05%0.0615.26%149.240.03%0.7318.46
Narayana Hrudayalaya39,014.5047.788.6017.76%0.7611.42%127.100.24%0.7624.77
Dr. Lal Path Labs32,171.6058.8812.8320.13%0.0825.56%147.341.07%0.9130.45
KRISHNA INST OF MED SCI L32,456.00166.908.6610.74%0.637.99%93.540.00%0.426.52
Poly Medicure17,713.4056.615.7010.37%0.0812.71%301.170.20%0.4833.15

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

TRANSGENE BIOTEK LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.26₹0.23₹0.06₹0.09
Other Income₹0.78₹0.18₹0.18₹0.21
Total Revenue₹1.04₹0.42₹0.23₹0.30
Total Expenses₹1.72₹1.07₹6.24₹10.70
Profit Before Tax-₹0.68-₹0.66-₹6.01-₹10.40
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹0.68-₹0.66-₹6.01-₹10.40
EPS - Basic-₹0.09-₹0.09-₹0.79-₹1.37
EPS - Diluted-₹0.09-₹0.09-₹0.79-₹1.37

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.68-₹0.66-₹6.01-₹10.40
Income before WC changes-₹0.52-₹0.61-₹1.05-₹0.43
Change in Assets₹0.12-₹0.06-₹0.13-₹0.05
Change in Liabilities₹1.60₹0.67₹1.18₹0.58
Change in WC₹1.72₹0.61₹1.05₹0.52
Cash flow from Operations₹1.20₹0.00₹0.00₹0.10
Cash flow from Investing-₹1.70₹0.00-₹0.01-₹0.10
Cash flow from Financing₹0.78₹0.00₹0.00₹0.00
Total Cash Flow₹0.28₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.00₹0.02₹0.01
Cash (End of the year)₹0.28₹0.01₹0.00₹0.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹142.83₹141.22₹141.31₹146.40
Current Assets₹1.26₹1.11₹1.04₹0.70
Total Assets₹144.09₹142.33₹142.36₹147.10
Current Liabilities₹12.74₹11.14₹10.47₹9.21
Net Current Asset-₹11.47-₹10.03-₹9.42-₹8.51
Non-Current Liabilities₹121.32₹120.48₹120.52₹120.52
Equity Capital₹10.03₹10.71₹11.37₹17.38
Total Equity & Liabilities₹144.09₹142.33₹142.36₹147.10

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.26₹0.23₹0.06₹0.09
Other Income₹0.78₹0.18₹0.18₹0.21
Total Revenue₹1.04₹0.42₹0.23₹0.30
Total Expenses₹1.72₹1.07₹6.24₹10.70
Profit Before Tax-₹0.68-₹0.66-₹6.01-₹10.40
Tax₹0.00₹0.00₹0.00₹0.00
Profit After Tax-₹0.68-₹0.66-₹6.01-₹10.40
EPS - Basic-₹0.09-₹0.09-₹0.79-₹1.37
EPS - Diluted-₹0.09-₹0.09-₹0.79-₹1.37

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.68-₹0.66-₹6.01-₹10.40
Income before WC changes-₹0.52-₹0.61-₹1.05-₹0.43
Change in Assets₹0.12-₹0.06-₹0.13-₹0.05
Change in Liabilities₹1.59₹0.67₹1.18₹0.58
Change in WC₹1.71₹0.61₹1.05₹0.52
Cash flow from Operations₹1.20₹0.00₹0.00₹0.10
Cash flow from Investing-₹1.70₹0.00-₹0.01-₹0.10
Cash flow from Financing₹0.78₹0.00₹0.00₹0.00
Total Cash Flow₹0.28₹0.00-₹0.01₹0.00
Cash (Start of the year)₹0.01₹0.00₹0.02₹0.01
Cash (End of the year)₹0.28₹0.01₹0.00₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹32.95₹31.34₹31.44₹36.53
Current Assets₹1.26₹1.10₹1.04₹0.69
Total Assets₹34.20₹32.44₹32.48₹37.22
Current Liabilities₹12.63₹11.04₹10.36₹9.10
Net Current Asset-₹11.37-₹9.93-₹9.33-₹8.41
Non-Current Liabilities₹29.12₹28.28₹28.32₹28.32
Equity Capital-₹7.55-₹6.87-₹6.21-₹0.20
Total Equity & Liabilities₹34.20₹32.44₹32.48₹37.22
* All values are in INR Crore
Qty
Bid
2431
2.78
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 2431
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
50.57
Neutral
ATR (14)
0.24
Neutral
STOCH(9,6)
74.29
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
18.33
Bullish
UO(9)
45.59
Neutral
ROC(12)
0.35
Bullish
WillR(14)
-59.38
Neutral
Period
Simple value
Exponential vaue
5D
2.79
2.81
10D
2.8
2.8
20D
2.82
2.83
50D
2.93
2.89
100D
2.99
2.9
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep0L
4 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
TRANSGENE BIOTEK LTD. Share Price
TRANSGENE BIOTEK LTD.
Healthcare Services
Add Stock
Add Another

TRANSGENE BIOTEK LTD. Share Price FAQs

TRANSGENE BIOTEK LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837